| Health Care Equipment & Supplies Industry | Healthcare Sector | Oded Bashan CEO | ASX Exchange | Q6S83Q101 CUSIP |
| IL Country | 3 Employees | - Last Dividend | 19 May 2023 Last Split | - IPO Date |
IR-Med Inc. operates as a development stage medical device company, with a primary focus on creating non-invasive devices tailored for various medical needs. Situated in Rosh Pina, Israel, the company commits itself to innovation in the medical field, aiming to enhance patient care and diagnostic procedures using cutting-edge technology. Their mission is evident in the development of devices like PressureSafe and Nobiotics, which represent significant advancements in medical diagnostics and patient care, especially in areas that have traditionally relied on invasive methods or extensive wait times for results.
A revolutionary handheld optical monitoring device from IR-Med Inc., PressureSafe is designed to aid in the early detection of pressure injuries to the skin and underlying tissue. These injuries are primarily caused by prolonged pressure, often associated with bed confinement, making this device particularly useful in clinical settings where patients are at risk of developing such conditions. Its non-invasive nature not only allows for quicker assessments but also significantly reduces the discomfort associated with traditional methods of detection.
The Nobiotics otoscope is another innovative device by IR-Med Inc., engineered to assist physicians by providing immediate indications of mid-ear infections, a common ailment particularly in children. This tool simplifies and speeds up the diagnosis process, potentially improving outcomes by facilitating quicker treatment strategies. Its design and functionality highlight IR-Med Inc.'s dedication to enhancing diagnostic procedures, reducing the strain on both medical professionals and patients, and paving the way for more efficient and effective healthcare solutions.